Holen Sie sich die Stockscreener-App
8.19
2.50%
0.20
Handel nachbörslich:
8.14
-0.05
-0.61%
Schlusskurs vom Vortag:
$7.99
Offen:
$8.1104
24-Stunden-Volumen:
23,440
Relative Volume:
0.01
Marktkapitalisierung:
$4.38M
Einnahmen:
$1.75M
Nettoeinkommen (Verlust:
$-5.68M
KGV:
-1.6808
EPS:
-4.8726
Netto-Cashflow:
-
1W Leistung:
+13.91%
1M Leistung:
+2,667%
6M Leistung:
+1,305%
1J Leistung:
+1,117%
1-Tages-Spanne:
$7.90
$8.22
1-Wochen-Bereich:
$7.20
$8.50
52-Wochen-Spanne:
$0.197
$8.50
Scisparc Ltd Stock (SPRC) Company Profile
Vergleichen Sie SPRC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
8.19 | 3.84M | 1.75M | -5.68M | 0 | -4.8726 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Scisparc Ltd Aktie (SPRC) Neueste Nachrichten
SciSparc Ltd. Executes Reverse Share Split Amid Financial Challenges - TipRanks
SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification - mg Magazine
IKNA issues special CVR dividend ahead of Inmagene merger | SPRC SEC FilingForm F-3/A - Stock Titan
What analysts say about SciSparc Ltd. stockSkyrocketing profit margins - jammulinksnews.com
SciSparc Ltd. Stock Analysis and ForecastRapid capital growth - jammulinksnews.com
SciSparc Ltd. Regains Nasdaq Compliance - TipRanks
SciSparc Ltd. Regains Compliance with Nasdaq Listing Rule 5550(a)(2) - Quiver Quantitative
SciSparc Clears Critical Nasdaq Hurdle: Stock Maintains $1 Minimum for 10 Straight Days - Stock Titan
How SciSparc Ltd. stock performs during market volatilityVerified Chart Patterns - Newser
What drives SciSparc Ltd. stock priceRapid profit acceleration - jammulinksnews.com
Is SciSparc Ltd. a good long term investmentSuperior risk-adjusted returns - jammulinksnews.com
how scisparc ltd. stock performs during market volatilityFree Stock Investment Discussion Area - Newser
SciSparc regains compliance with Nasdaq minimum bid price notification - TipRanks
Why SciSparc Ltd. stock attracts strong analyst attentionMarket Beating Strategy - Newser
What makes SciSparc Ltd. stock price move sharplyTrend Based Entry Alerts - Newser
SciSparc (NASDAQ:SPRC) Trading Up 10.2% – What’s Next? - Defense World
IM Cannabis Strengthens Leadership: Lands $1M Strategic Funding and Cannabis Industry Veteran Director - Stock Titan
SciSparc Announces Expanding its Clinical Operations to Include a U.S. Site Towards its Phase IIb Trial with its Proprietary SCI-110 for the Treatment of Tourette Syndrome - Barchart.com
SciSparc Announces Reverse Share Split Effective July 3, 2025 - TipRanks
SciSparc Announces 1-for-21 Reverse Share Split - mg Magazine
SciSparc Stock Set to Reverse Split on Thursday, July 3rd (NASDAQ:SPRC) - Defense World
SciSparc Ltd. Shareholders Approve Key Proposals at Annual Meeting - TipRanks
SciSparc Ltd. Adjourns Annual Meeting Due to Lack of Quorum - TipRanks
SciSparc announces 1-for-21 reverse stock split - TipRanks
SciSparc to Implement 1-for-21 Reverse Stock Split - MarketScreener
SciSparc Ltd. Advances Merger with AutoMax Motors - TipRanks
SciSparc announces publication of Japanese patent application - MSN
Therapix Biosciences Ltd. Announces Executive Changes - marketscreener.com
SciSparc Unveils Japanese Patent for Novel Pain Relief Combination - TipRanks
SciSparc secures Japanese patent for pain relief combo By Investing.com - Investing.com South Africa
SciSparc Ltd. Announces Publication of Japanese Patent Application - marketscreener.com
SciSparc secures Japanese patent for pain relief combo - Investing.com
SciSparc Ltd. Announces Publication of Novel Japanese Patent for Enhanced Pain Management Therapy Combining Paracetamol and PEA - Nasdaq
SciSparc Announces Publication of Japanese Patent Application - GlobeNewswire
Finanzdaten der Scisparc Ltd-Aktie (SPRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):